Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001477932-22-006410
Filing Date
2022-08-23
Accepted
2022-08-23 12:25:45
Documents
2
Period of Report
2022-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1614
2 POWER OF ATTORNEY cure_ex24.htm EX-24 8337
  Complete submission text file 0001477932-22-006410.txt   11335
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Issuer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address
BAGG GERALD (Reporting) CIK: 0001941325 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55908 | Film No.: 221186122